1. Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant. (March 2022) Authors: Malorni, Luca; Tyekucheva, Svitlana; Hilbers, Florentine S.; Ignatiadis, Michail; Neven, Patrick; Colleoni, Marco; Henry, Stéphanie; Ballestrero, Alberto; Bonetti, Andrea; Jerusalem, Guy; Papadimitriou, Konstantinos; Bernardo, Antonio; Seles, Elena; Duhoux, Francois P.; MacPherson, Iain R.; Thoms... Journal: European journal of cancer Issue: Volume 164(2022) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗